KNSA
Kiniksa Pharmaceuticals International, plc
Latest Form 4:Sale$299KbyCole G Bradley (Director) · filed Jul 31, 2026
Kiniksa Pharmaceuticals International, plc (KNSA) has 60 SEC Form 4 filings (185 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 21, 2026.
The most active filer is CHIEF OPERATING OFFICER Tessari Eben with 9 filings. Insiders have net sold $37.8M over the trailing 6 months.
- Industry:Medical - Pharmaceuticals
- CEO:Sanj K. Patel
- Employees:366
- HQ:London, MA, GB
- IPO:2018-05-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66.7M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$6.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Cole G BradleyFirst in 5 months | Director | Sale | 3,673 | $299K | Jul 31 | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 58,424 | $3.1M | May 5 | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 48,565 | $2.6M | May 1 | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 483,654 | $25.1M | Apr 30 | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 22,544 | $1.2M | Apr 30 | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 2,141 | $116K | Apr 30 | SEC ↗ | |
| Director | Sale | 13,099 | $656K | Apr 29 | SEC ↗ | |
Megna Michael RFirst in 6 months | CHIEF ACCOUNTING OFFICER | Sale | 6,625 | $309K | Apr 13 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 1,703 | $80K | Apr 13 | SEC ↗ | |
Patel Sanj KFirst in 6 months | CHAIRMAN & CEO | Sale | 7,278 | $364K | Apr 8 | SEC ↗ |
Moat RossFirst in 7 months | CHIEF OPERATING OFFICER | Sale | 2,367 | $115K | Apr 8 | SEC ↗ |
| Director | Sale | 6,901 | $345K | Apr 8 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 36,722 | $1.7M | Mar 11 | SEC ↗ | |
Paolini John F.First in 4 months | CHIEF MEDICAL OFFICER | Sale | 40,000 | $1.8M | Mar 4 | SEC ↗ |
| Director | Sale | 110 | $5K | Feb 12 | SEC ↗ | |
| Director | Sale | 2,690 | $121K | Feb 12 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 17,845 | $772K | Feb 11 | SEC ↗ | |
| Director | Sale | 830 | $37K | Feb 4 | SEC ↗ | |
| Director | Sale | 12,528 | $567K | Feb 4 | SEC ↗ | |
| Director | Sale | 2,602 | $117K | Feb 4 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 12,000 | $503K | Jan 9 | SEC ↗ | |
Quart Barry DFirst filing | Director | Sale | 20,129 | $836K | Dec 17 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 12,048 | $501K | Dec 17 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 42,841 | $1.8M | Dec 10 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 200 | $9K | Dec 1 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 12,470 | $514K | Nov 19 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 19,900 | $815K | Nov 14 | SEC ↗ | |
Paolini John F.First filing | CHIEF MEDICAL OFFICER | Sale | 82,542 | $3.1M | Nov 4 | SEC ↗ |
Ragosa MarkFirst filing | CHIEF FINANCIAL OFFICER | Sale | 100 | $4K | Oct 30 | SEC ↗ |
| CHIEF ACCOUNTING OFFICER | Sale | 50,490 | $2.0M | Oct 22 | SEC ↗ | |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 121,248 | $4.7M | Oct 22 | SEC ↗ |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 39,331 | $1.5M | Oct 22 | SEC ↗ |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 97,390 | $3.8M | Oct 22 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 12,368 | $466K | Oct 16 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 42,000 | $1.6M | Oct 1 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 16,400 | $598K | Sep 17 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 85,271 | $3.0M | Sep 8 | SEC ↗ | |
| CHIEF OPERATING OFFICER | Sale | 13,389 | $477K | Sep 8 | SEC ↗ | |
Moat RossFirst filing | CHIEF CORP. & COMM. OFFICER | Sale | 3,523 | $124K | Sep 8 | SEC ↗ |
Megna Michael RFirst filing | CHIEF ACCOUNTING OFFICER | Sale | 11,000 | $383K | Sep 3 | SEC ↗ |
Tessari EbenFirst filing | CHIEF OPERATING OFFICER | Sale | 15,091 | $536K | Sep 3 | SEC ↗ |
Related companies
Kiniksa Pharmaceuticals International, plc is in the Healthcare sector.